Multiple fields may offer better esophagus sparing without increased probability of lung toxicity in optimized IMRT of lung tumors.

International Journal of Radiation Oncology, Biology, Physics
Olivier ChapetRandall K Ten Haken

Abstract

To evaluate whether increasing numbers of intensity-modulated radiation therapy (IMRT) fields enhance lung-tumor dose without additional predicted toxicity for difficult planning geometries. Data from 8 previous three dimensional conformal radiation therapy (3D-CRT) patients with tumors located in various regions of each lung, but with planning target volumes (PTVs) overlapping part of the esophagus, were used as input. Four optimized-beamlet IMRT plans (1 plan that used the 3D-CRT beam arrangement and 3 plans with 3, 5, or 7 axial, but predominantly one-sided, fields) were compared. For IMRT, the equivalent uniform dose (EUD) in the whole PTV was optimized simultaneously with that in a reduced PTV exclusive of the esophagus. Normal-tissue complication probability-based costlets were used for the esophagus, heart, and lung. Overall, IMRT plans (optimized by use of EUD to judiciously allow relaxed PTV dose homogeneity) result in better minimum PTV isodose surface coverage and better average EUD values than does conformal planning; dose generally increases with the number of fields. Even 7-field plans do not significantly alter normal-lung mean-dose values or lung volumes that receive more than 13, 20, or 30 Gy. Optimized many-fi...Continue Reading

References

May 15, 1991·International Journal of Radiation Oncology, Biology, Physics·C BurmanM Goitein
Jun 1, 1989·International Journal of Radiation Oncology, Biology, Physics·G J Kutcher, C Burman
Mar 1, 1985·Medical Physics·T R MackieJ J Battista
Feb 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B JeremicL Djuric
Apr 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J S LeeW J Curran
Mar 15, 1997·International Journal of Radiation Oncology, Biology, Physics·J M RobertsonA S Lichter
Oct 23, 1997·International Journal of Radiation Oncology, Biology, Physics·L B MarksM Anscher
Jul 1, 1999·International Journal of Radiation Oncology, Biology, Physics·J W WongA A Martinez
Sep 16, 1999·International Journal of Radiation Oncology, Biology, Physics·M V GrahamC A Perez
Oct 19, 1999·International Journal of Radiation Oncology, Biology, Physics·J HanleyG J Kutcher
Aug 5, 2000·International Journal of Radiation Oncology, Biology, Physics·K E RosenzweigS A Leibel
Sep 7, 2000·International Journal of Radiation Oncology, Biology, Physics·W A Tomé, J F Fowler
Nov 10, 2000·International Journal of Radiation Oncology, Biology, Physics·D MahG Mageras
Sep 18, 2001·International Journal of Radiation Oncology, Biology, Physics·J O Deasy
Dec 1, 2001·International Journal of Radiation Oncology, Biology, Physics·M EngelsmanE M Damen
Jan 5, 2002·International Journal of Radiation Oncology, Biology, Physics·Qiuwen WuRupert Schmidt-Ullrich
Apr 17, 2002·International Journal of Radiation Oncology, Biology, Physics·K A VinebergB A Fraass
Jul 4, 2002·International Journal of Radiation Oncology, Biology, Physics·Yvette SeppenwooldeKazuo Miyasaka
Jul 20, 2002·International Journal of Radiation Oncology, Biology, Physics·John R van Sörnsen de KosteSuresh Senan
Nov 16, 2002·Physics in Medicine and Biology·Beong Choi, Joseph O Deasy
Feb 1, 2003·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Sara C ErridgeJoos V Lebesque
Feb 8, 2003·International Journal of Radiation Oncology, Biology, Physics·Yvette SeppenwooldeRandall K Ten Haken
Mar 22, 2003·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·José S A BelderbosJoos V Lebesque
May 2, 2003·Medical Physics·Indrin J ChettyAlex F Bielajew
Oct 8, 2003·International Journal of Radiation Oncology, Biology, Physics·Elena M WilsonEdwin G A Aird
Nov 25, 2003·International Journal of Radiation Oncology, Biology, Physics·Kai-Liang WuShen Zhao
Nov 25, 2003·International Journal of Radiation Oncology, Biology, Physics·Patrick C F CheungYee C Ung
Mar 6, 2004·International Journal of Radiation Oncology, Biology, Physics·Hasan MurshedJoe Y Change
Mar 6, 2004·International Journal of Radiation Oncology, Biology, Physics·H Helen LiuRadhe Mohan
Nov 24, 2004·Seminars in Radiation Oncology·Suresh SenanRandall K Ten Haken
Dec 14, 2004·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Caroline L HollowayWilson H Roa
Apr 9, 2005·International Journal of Radiation Oncology, Biology, Physics·Takayuki HashimotoKazuo Miyasaka
May 12, 2005·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Wilfried De Neve, Carlos De Wagter
May 14, 2005·International Journal of Radiation Oncology, Biology, Physics·Marco SchwarzEugène M F Damen
May 14, 2005·International Journal of Radiation Oncology, Biology, Physics·Emma ThomasRandall K Ten Haken
May 18, 2005·Medical Physics·Jan-Jakob SonkeMarcel van Herk
Jun 9, 2005·International Journal of Radiation Oncology, Biology, Physics·Ellen D YorkeC Clifton Ling
Jul 12, 2005·International Journal of Radiation Oncology, Biology, Physics·Patrick A KupelianKatja M Langen
Aug 23, 2005·International Journal of Radiation Oncology, Biology, Physics·Olivier ChapetRandall K Ten Haken

❮ Previous
Next ❯

Citations

Feb 6, 2014·International Journal of Radiation Oncology, Biology, Physics·Jeremy P HarrisMaximilian Diehn
Sep 4, 2015·Clinical Oncology : a Journal of the Royal College of Radiologists·R K ShrimaliS Chatterjee
May 9, 2012·International Journal of Radiation Oncology, Biology, Physics·Margriet KwintJosé Belderbos
Oct 5, 2010·International Journal of Radiation Oncology, Biology, Physics·Yolande LievensUNKNOWN Leuven Lung Cancer Group
Mar 12, 2010·Seminars in Radiation Oncology·Jan-Jakob Sonke, José Belderbos
Feb 6, 2008·International Journal of Radiation Oncology, Biology, Physics·Yulia LyatskayaAaron M Allen
Aug 21, 2007·International Journal of Radiation Oncology, Biology, Physics·Lawrence B Marks, Jinli Ma
May 29, 2007·International Journal of Radiation Oncology, Biology, Physics·Manuel AlgaraXavier Sanz
Nov 22, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Anna SimeonovaFrank Lohr
Sep 17, 2013·Journal of Applied Clinical Medical Physics·Xiance JinCongying Xie
Oct 16, 2009·Expert Review of Anticancer Therapy·José Belderbos, Jan Jakob Sonke

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved